International Business Strategies:Weijie Pharmaceuticals main clients are based in the United States, Europe and other regions with well-developed pharmaceutical industries providing raw materials with US Food and Drug Administration (FDA) and the EU standards. With a view to further expanding international business, Weijie Pharmaceuticals has established branch offices in Boston (US) and Basel (Switzerland) and formed a manufacturing and marketing framework supported by the production base in China and sales centers located in the US and Europe.

Leadership Integrating West and East: The core managerial team of Weijie Pharmaceuticals consists of professionals with previous working experience in world-class pharmaceutical companies in China, the US and Europe, including extensive practical knowledge in bio-pharmacy. Weijie Pharmaceuticals now meets stringent production standards set by the global pharmaceutical industry and has also gained a broader global perspective.

Professional Technological Backbones: Weijie Pharmaceuticals has proactively developed a company-wide talent acquisition and nurturing process in which all the R&D and project directors are graduates from nationally renowned universities and specialized in chemistry or bio-pharmacy. The highly motivated staff are equipped with a solid theoretical foundation and world-class practical expertise which is consistently monitored, encouraged and further enhanced.

State-of-the-art Technological Reserve: Weijie Pharmaceuticals has successfully applied a host of technical patents related to chemistry and pharmacy in both China and the US. The company also participated in the R&D process of 505(b) preparations in the US, which supported the expansion of our manufacturing projects.

Our business vision is to accelerate our presence within the international framework and to continuously promote our diverse portfolio.  By adhering to the cost advantages offered within China, we aim to continuously foster and develop our manufacturing capacity meeting the global standards required for major pharmaceutical raw materials.